Labor Market Pulse · Life Sciences · September 2026
Life Sciences Labor Market Report: SC NONMETROPOLITAN AREA — September 2026
Nonmetro SC scientific pay diverges sharply from national trend.
Research Scientist advertised pay fell to a $103,775 metro median even as the national figure climbed to $131,354, while Biostatistician pay locally jumped to $157,134 — a split signaling uneven talent pressure across nonmetro South Carolina's life sciences roles.
Free archive edition. Published by WageScape as sent to subscribers; data as of September 2026.
Key indicators
- SC statewide unemployment: 4.1% — August 2026, down 0.1pt month-over-month
- Research Scientist advertised pay: $103,775 — Metro median, down vs $131,354 national, up
- Biostatistician advertised pay: $157,134 — Metro median, up significantly vs $133,322 national
- SC life sciences wage premium: 17% — $102,000 avg life sci vs $87,369 state avg wage
Key takeaways
Rural CDMO growth is pulling talent before building pipeline.
Ritedose's Newberry College partnership points to proactive workforce development, but sterile manufacturing and validation engineering remain scarce specialties — advertised Validation Engineer pay climbed to $114,497 metro median, up significantly, reflecting that scarcity in real time.
Regulatory Affairs pay has gone flat, and that is itself a signal.
Metro Regulatory Affairs Specialist pay sits at $107,432, essentially stable, even as national commentary describes regulatory talent as a structural bottleneck. Flat local pay in a nationally scarce function may suggest nonmetro employers are under-pricing a role competitors in Charleston or Research Triangle markets are actively bidding up.
Clinical research pay is outpacing the state's own wage growth.
Clinical Research Associate advertised pay rose to a $100,686 metro median, outperforming South Carolina's already-strong 4.0% statewide weekly wage growth. Nonmetro employers recruiting CRAs should expect to compete against this upward trend rather than assume rural geography suppresses clinical talent costs.
Lab Technician wage gains don't match the scientific talent story.
Metro Lab Technician pay rose to $49,920 even as national Lab Technician pay moved down moderately, diverging from broader softening in entry-level scientific wages. Localized upward pressure on this feeder role may reflect nonmetro employers competing harder for a thinner entry-level bench, with downstream effects on R&D and QA pipeline costs.
Median advertised pay by role — SC NONMETROPOLITAN AREA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist | $88,122 | $103,775 | $112,948 | Significant decline | $131,354 |
| Clinical Research Associate | $57,168 | $100,686 | $111,169 | Significant increase | $90,956 |
| Lab Technician | $45,017 | $49,920 | $59,684 | Significant increase | $47,402 |
| Regulatory Affairs Specialist | $87,229 | $107,432 | $135,481 | Stable | $104,000 |
| Clinical Data Manager | $108,380 | $117,299 | $133,669 | Significant decline | $123,031 |
| Biostatistician | $131,082 | $157,134 | $157,134 | Significant increase | $133,322 |
| Validation Engineer * | $90,855 | $114,497 | $141,344 | Significant increase | $108,377 |
* State-level figure shown where metro postings were too few.
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
Rural South Carolina labor markets remain tighter than headline state figures suggest, with the 4.1% state unemployment rate masking sharper competition for credentialed scientific and manufacturing talent outside Charleston, Columbia, and Greenville metro cores. Ritedose's CDMO expansion and workforce partnerships with institutions like Newberry College signal that life sciences manufacturing investment is pushing into nonmetro counties, pulling skilled labor away from a thin rural talent base already stretched by 2.4% annualized employment growth statewide.
What it means
Nonmetro life sciences employers compete for the same regulatory, quality, and manufacturing talent pool as Charleston and Upstate metro operations, but without the density of academic and CRO/CDMO infrastructure that supports faster backfill — extending time-to-fill for specialized roles and raising the cost of mis-hires. Build-vs-outsource calculus shifts as rural CDMO capacity like Ritedose's expands, making regional contract manufacturing a credible alternative to recruiting scarce process development and validation talent in-house. Consider evaluating whether nonmetro manufacturing and quality roles should be benchmarked against regional CDMO wage pressure rather than statewide averages, given the premium these specialized hires command locally.
Looking ahead
Worth watching: DP World's September 1 WARN filing (205 workers, Spartanburg) adds to manufacturing-sector displacement statewide. Watch whether any logistics or advanced manufacturing talent with transferable quality or validation skills enters the nonmetro life sciences candidate pool.
Emerging pressure point: Research Scientist advertised pay fell significantly in this metro ($103,775) while national pay rose to $131,354 — a widening gap that could accelerate outmigration of PhD-level talent toward Boston, Research Triangle, or remote-eligible national employers over the next two quarters.
Potential inflection point: Biostatistician pay jumped to a $157,134 metro median, up significantly and now exceeding the national median. Confirm whether this reflects a genuine local shortage or a small-sample spike tied to a handful of high-value postings before resetting internal pay bands.
Expected: Continued CDMO and manufacturing investment statewide, paired with Department of Commerce's life sciences growth priority, suggests nonmetro validation, process development, and quality roles will stay difficult to fill through year-end. Build-vs-outsource decisions should factor in extended requisition timelines, not just base pay.
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.